Unknown OBSERVATIONAL NCT05196594

Analysis of the Instestinal Microbiome of Patients With Transthyretin Amyloidosis (AMIAT)

Analysis of the Intestinal Microbiome of Patients With Transthyretin Amyloidosis

Sponsor: University of Sao Paulo General Hospital

Conditions Amyloidosis, Hereditary, Transthyretin-Related Microbial Colonization

Interventions collection of stools for genetic analysis

Updated 5 times since 2022 Last updated: Jan 17, 2022 Started: May 1, 2021 Primary completion: May 31, 2023 Completion: May 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Amyloidosis, Hereditary, Transthyretin-Related and Microbial Colonization and is currently ongoing. University of Sao Paulo General Hospital leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown
Sep 2024 — Sep 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Feb 2022 — Nov 2023 [monthly]

Recruiting

First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Sao Paulo General Hospital

Data source: University of Sao Paulo General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil